Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia.

[1]  M. Laakso,et al.  How good a marker is insulin level for insulin resistance? , 1993, American journal of epidemiology.

[2]  M. Taskinen,et al.  Effects of Gemfibrozil on Low-Density Lipoprotein Particle Size, Density Distribution, and Composition in Patients With Type II Diabetes , 1993, Diabetes Care.

[3]  M. Laakso,et al.  Effects of bezafibrate on insulin sensitivity and glucose tolerance in subjects with combined hyperlipidemia , 1992, Clinical pharmacology and therapeutics.

[4]  J. Tuomilehto,et al.  Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers. , 1992, Archives of internal medicine.

[5]  S. Haffner,et al.  Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X) , 1992, Diabetes.

[6]  G. Steiner.  Altering Triglyceride Concentrations Changes Insulin-Glucose Relationships in Hypertriglyceridemic Patients: Double-Blind Study With Gemfibrozil With Implications for Atherosclerosis , 1991, Diabetes Care.

[7]  L. Groop,et al.  Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. , 1991, The American journal of physiology.

[8]  M. Tikkanen,et al.  Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozil , 1991, Journal of internal medicine.

[9]  W. J. Andrews,et al.  The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia. , 1990, Metabolism: clinical and experimental.

[10]  M. Laakso,et al.  Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. , 1990, Arteriosclerosis.

[11]  R. DeFronzo,et al.  Time dependence of the interaction between lipid and glucose in humans. , 1989, The American journal of physiology.

[12]  A. Consoli,et al.  Mechanism for Underestimation of Isotopically Determined Glucose Disposal , 1989, Diabetes.

[13]  B. Capaldo,et al.  Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes. , 1989, Atherosclerosis.

[14]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[15]  P. Raskin,et al.  Relationship between lipoprotein levels and in vivo insulin action in normal young white men. , 1988, Metabolism: clinical and experimental.

[16]  M. Taskinen,et al.  Interrelationships Among Insulin's Antilipolytic and Glucoregulatory Effects and Plasma Triglycerides in Nondiabetic and Diabetic Patients With Endogenous Hypertriglyceridemia , 1988, Diabetes.

[17]  S. Grundy,et al.  Hypertriglyceridemia: Causes and Relation to Coronary Heart Disease , 1988, Seminars in thrombosis and hemostasis.

[18]  M. Taskinen,et al.  Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent Diabetes , 1988, Arteriosclerosis.

[19]  J. Huttunen,et al.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.

[20]  H. Yki-Järvinen,et al.  Kinetics of glucose disposal in whole body and across the forearm in man. , 1987, The Journal of clinical investigation.

[21]  J. Olefsky,et al.  In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. , 1986, The Journal of clinical investigation.

[22]  I. Roberts,et al.  A Simple Method for the Measurement of Glycerol in Serum , 1986, Annals of clinical biochemistry.

[23]  G. Steiner,et al.  Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications. , 1986, The American journal of cardiology.

[24]  S. Grundy,et al.  Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man , 1984 .

[25]  R. DeFronzo,et al.  Effect of long chain triglyceride infusion on glucose metabolism in man. , 1982, Metabolism: clinical and experimental.

[26]  J C Stanley,et al.  The glucose-fatty acid cycle. Relationship between glucose utilization in muscle, fatty acid oxidation in muscle and lipolysis in adipose tissue. , 1981, British journal of anaesthesia.

[27]  M. Vranic,et al.  Resistance to Insulin but Not to Glucagon in Lean Human Hypertriglyceridemics , 1980, Diabetes.

[28]  P. Dunn,et al.  A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography. , 1978, Metabolism: clinical and experimental.

[29]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[30]  W D Gennaro,et al.  Quantitation of free, total, and antibody-bound insulin in insulin-treated diabetics. , 1975, Clinical chemistry.

[31]  G. Reaven,et al.  Reappraisal of the role of insulin in hypertriglyceridemia. , 1974, The American journal of medicine.

[32]  M. Berman,et al.  Interrelations in the oxidative metabolism of free fatty acids, glucose, and glycerol in normal and hyperlipemic patients. A compartmental model. , 1974, The Journal of clinical investigation.

[33]  J. Sternberg,et al.  A New and Rapid Method for the Determination of Glucose by Measurement of Rate of Oxygen Consumption , 1968 .

[34]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.

[35]  P. Winocour,et al.  Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteins. , 1992, Atherosclerosis.

[36]  M. Jensen,et al.  Measurement of non-steady-state free fatty acid turnover. , 1990, The American journal of physiology.

[37]  R N Bergman,et al.  Assessment of insulin sensitivity in vivo. , 1985, Endocrine reviews.

[38]  J. Aikens,et al.  A microfluorometric method for the determination of free fatty acids in plasma. , 1983, Journal of lipid research.